-

VitalConnect Appoints Amy Covert as Chief Financial Officer

Addition of Experienced Financial Leader Bolsters Strong Management Team

SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the appointment of Amy Covert to the position of Chief Financial Officer, effective August 8, 2022. Covert brings more than 20 years of experience to the role, in both public and private companies, primarily within healthcare. She joins VitalConnect from HoverTech International, a medical device company, where she had served as CFO since 2019. At HoverTech, Covert had responsibility for finance and accounting as well as the operational organization which included manufacturing, sourcing, customer service and logistics. Prior to HoverTech, she held various financial leadership roles at BioTelemetry, Inc., a remote cardiac monitoring company.

Covert received her Master of Business Administration and a Certificate in Accountancy from Villanova University. She graduated with a Bachelor of Science in Finance and International Business from The Pennsylvania State University.

“Amy brings a wealth of experience in building high-performance finance teams and driving organizational change to VitalConnect,” said Peter Van Haur, CEO of VitalConnect. “Over the past few years, we’ve attracted tremendous talent to the leadership team with the common goal of improving outcomes for physicians and patients. Adding a strong financial leader with Amy’s experience will allow VitalConnect to accelerate our already rapid growth in cardiac monitoring and remote patient management.”

Founded in 2011, VitalConnect has deployed more than 200,000 patches throughout the world, including to leading acute-care facilities such as Brigham and Women’s Hospital, Hackensack Medical Center, Northwell Health and John Radcliffe Hospital-Oxford University. The VitalPatch allows real-time remote or in-hospital monitoring, allowing physicians to optimize the delivery of care to their patients.

About VitalConnect, Inc.

VitalConnect is a leader in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations. VitalConnect leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms that achieve better health and economic outcomes. VitalConnect’s products are designed for use in a broad range of inpatient and outpatient settings, such as hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions. For more information: www.vitalconnect.com.

Contacts

Media Contacts:
Steve Kelly
VitalConnect, Inc.
206-856-6488
skelly@vitalconnect.com

VitalConnect, Inc.


Release Versions

Contacts

Media Contacts:
Steve Kelly
VitalConnect, Inc.
206-856-6488
skelly@vitalconnect.com

Social Media Profiles
More News From VitalConnect, Inc.

VitalConnect, Inc. Secures $100 Million in Financing

SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect®, Inc., a leader in biosensor technology, specializing in ambulatory cardiac monitoring, today announced the closing of $100 million in financing through a combination of equity and debt capital. The equity financing was led by new investor Ally Bridge Group, with significant participation from the Company’s existing investors, including EW Healthcare Partners, MVM and Revelation Partners while Trinity Capital provided the debt financing. In conju...

VitalConnect Secures over $30 Million in Oversubscribed Series F Financing

SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced closing on an oversubscribed Series F financing in excess of $30 million. The financing round was led by Revelation Partners with significant participation from the company’s existing investors, including Pacific General Ventures and EW Healthcare Partners. The additional funding will support VitalConnect’s rapidly growing remote cardiac monitoring business w...

VitalConnect Announces Investment from HCA Healthcare to Accelerate Commercial Growth and Create Strategic Partnership

SAN JOSE, Calif.--(BUSINESS WIRE)--VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one of the nation’s leading healthcare providers. The investment will go toward further accelerating VitalConnect’s rapidly growing cardiac monitoring business segment while advancing key Remote Patient Monitoring of individuals who have e...
Back to Newsroom